| 6D5Y: reference: ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor Therapy., Jaiswal BS, Durinck S, Stawiski EW, Yin J, Wang W, Lin E, Moffat J, Martin SE, Modrusan Z, Seshagiri S, Clin Cancer Res. 2018 Aug 15;24(16):4044-4055. doi:, 10.1158/1078-0432.CCR-17-3674. Epub 2018 May 14. PMID: 29760222 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).